Introduction
Although all nucleated mammalian cell types have the ability to produce type I interferons (IFNs) in response to infection by an appropriated virus, enabling neighboring cells to resist viral infection, human plasmacytoid pre-dendritic cells (pDCs), or type I IFN-producing cells (IPCs), have the ability to produce hundred to thousand times more type I IFNs than other cell types following encounters with both DNA and RNA viruses [1] [2] [3] [4] [5] [6] . This phenomenon together with the fact that human pDCs/IPCs selectively express toll-like receptor 7 (TLR7) and TLR9 [7] [8] [9] , which respectively recognize viral RNA and DNA 10, 11 ,
suggests that pDCs/IPCs are specialized in viral recognition and production of type I IFNs.
By contrast, human myeloid dendritic cells (mDCs) selectively express TLR2, TLR3, TLR4, TLR5, TLR6, and TLR8 and have the ability to produce high levels of interleukin (IL)-12, but only low levels of type I IFNs, upon bacterial and viral infection 7, 8 . These findings have led to an evolution model suggesting that there are two unique antigenpresenting cell (APC) systems in humans, with pDCs specialized in making type I IFNs and mDCs specialized in making IL-12. This hypothesis is challenged, however, by studies
showing that 1) in response to lipopolysaccharide (LPS) or CpG-oligodeoxynucleotide (ODN) plus CD40-ligand (CD40L), pDCs produced as much IL-12 as mDCs 2, 9 and 2) in response to electroporated poly(I:C), mDCs produced as much IFN-α as pDCs 12 . An alternative instruction model therefore has been proposed, suggesting that pDCs and mDCs have the functional plasticity to produce similar amounts of IFN-α and IL-12, depending on the stimulus.
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The question is whether the evolution model and the instruction model of DC development and maturation are mutually exclusive. Current literatures on DC subsets are very confusing. These confusions appear to be caused by species differences between human and mouse DC subsets 13 and different experimental conditions from different laboratories. For example the expression patterns of TLRs by DC subsets in mice and humans are different 13 . In mice, pDCs clearly have the ability to produce both IL-12 and IFN-α in response to viral stimulation 1, 14 . However in humans, pDCs appear to have a very limited ability to produce IL-12. In humans pDCs express very high levels of IL-3 receptor and are highly responsive to IL-3 stimulation 15 . By contrast mouse pDCs do not express IL-3 receptor and do not respond to IL-3 16 . Another important factor that contributes to the contradictory data on the function of DC subsets has been the different degree of purity of DC subsets used by different laboratories.
One particular focus of the debates was whether human pDCs and mDCs have equal ability to produce IL-12. By using highly purified human DC subsets and all the known TLR-ligands (TLRLs) and their combination with CD40L, we found that while pDCs preferentially produce type 1 IFNs, mDCs preferentially produce IL-12 regardless the type of the stimulation. We discovered several novel functional features of pDCs/IPCs that further support the concept that pDCs are professional type 1 IFN-producing cells.
We suggest that the functional plasticity of DCs is not unlimited. Experiments using DC subsets with low purity may generate confusing data about the functional plasticity of DCs. While pDCs preferentially produce type I IFNs, mDCs preferentially produce IL-12 during anti-microbial innate immune responses.
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Materials and Methods

Media and Reagents
Peptidoglycan (PGN from Bacillus subtillis, 5 μg/ml), zymosan (10 μg/ml), poly(I:C) (25 μg/ml), LPS (from E. coli 0111:B4; 1 μg/ml), flagellin (from Salmonella typhimurium, 5 μg/ml), loxoribine (100 μM), and R848 (1 μg/ml) were purchased from InvivoGen (San Diego, CA). CpG type A (2216, 5 μM), type B (2006, 5 μM), type C (C274, 5 μM), γ-irradiated herpes simplex virus (HSV)-1 (KOS strain; 10 PFU/cell), influenza virus (PR8 strain; 10 PFU/cell), Sendai virus (Cantell strain; 5 PFU/cell), anti-CD40 mAb (G28.5, 3 μg/ml) and IL-3 (10 ng/ml; R&D Systems, Minneapolis, MN) were used for cell stimulation.
Cell Isolation and Culture pDCs and CD11c + mDCs were isolated from buffy coat of blood from healthy volunteers obtained with informed consent as described 7, 17 human IFN-α Ab (2,000 neutralization U/ml), neutralizing rabbit anti-human IFN-β Ab
(1,000 neutralization U/ml), and mouse anti-human IFN-α/β receptor mAb (10 μg/ml) (all from PBL Biomedical Laboratories, Piscataway, NJ), or a mixture of rabbit IgG and mouse IgG (both from R&D) was added into mDC-pDC cocultures.
Measurement of Cytokine Production
Supernatants of each APC subsets were collected after 4, 8, 12, 24, 36 , and 48 hour after stimulation. After removal of supernatant and extensive cell wash, the adjusted number of the viable cells (10 5 cells/200 ul medium) were re-cultured for further 12 or 24 hours.
Production of IL-12 p70, IL-10, tumor necrosis factor-α (TNF-α), IL-6 (kits from R&D) and IFN-α (kits from PBL) in the supernatants was determined by ELISA. 
Intracellular Cytokine Analyses
Real-time PCR and Reverse transcriptase (RT)-PCR
Total RNA was extracted with the Qiagen RNeasy mini protocol and was converted to cDNA using oligo-dT, random hexamers, and SuperScript II RT (Invitrogen, Carlsbad, CA).
Real-time PCR was performed using a sequence detector (model ABI PRISM 9600;
PerkinElmer, Wellesley, MA) and target mixes (Applied Biosystems, Foster City, CA):
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Suppression subtractive hybridization
Suppression subtractive hybridization was performed with total RNA prepared after 6-8 hour incubation of purified pDCs with IL-3 (10 ng/ml) and HSV-1 (10 PFU/cell), or with IL-3 alone. Material from several donors was pooled for each condition. The cDNAs were amplified following the SMART™ technology protocol (BD Clontech, Palo Alto, CA). The subsequent hybridization was performed using IL-3 and HSV-1 cDNA as tester, and IL-3 cDNA as driver following the PCR-Select kit protocol (BD Clontech) generating a library enriched in HSV-1 induced pDC transcripts. Clones from this library were automatically sequenced (Applied Biosystems) and sequences compared against GenBank and dbEST databases using BLAST.
Ethical priciples
This study was approved by the Institutional Review Board at the University of Texas M.D.
Anderson Cancer Center, and abides by the tenets of the Declaration of Helsinki.
Results
Differential capacity of pDCs and mDCs to produce IL-12 and IFN-α in response to TLR signaling
To clarify the previous conflicting data on the ability of pDCs to produce IL-12 and the ability of mDCs to produce IFN-α, it is extremely important to carry out experiments using highly purified cell populations and the microbial ligand to each of the known TLRs.
Human pDCs, CD11c
+ mDCs, and CD14 + monocytes were isolated from peripheral blood by cell sorting to more than 99% purity. Monocytes were cultured with granulocytemacrophage colony-stimulating factor (GM-CSF) plus IL-4 for 5 days to generate immature monocyte-derived DCs (mono-DCs). pDCs, CD11c + mDCs, and mono-DCs were cultured with 10 TLRLs, and their ability to produce cytokines IFN-α and IL-12 p70 were evaluated by ELISA ( Figure 1 ). In consistent with their TLR expression pattern, pDCs produced IFN-α, but no IL-12, in response to TLR7Ls (loxoribine and R848) and TLR9Ls (CpGs A, B, and C). CD11c + mDCs and mono-DCs produced IL-12 p70 in response to TLR3L
(poly(I:C)), TLR4L (LPS), and TLR8L (R848) but only a small amount of IFN-α in response to TLR3L. The maximal IFN-α production by pDCs in response to CpG A was at least 150 times more than the maximal IFN-α produced by mDCs in response to poly(I:C) (97,568±9,054 pg/ml versus 601±183 pg/ml). These results confirm and extend the previous only.
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Cytokine production by pDCs and mDCs in response to TLR and CD40 dual signaling
A recent study suggested that human pDC/IPCs may require two signals mediated by TLRL and CD40L to produce IL-12 9 . We therefore examined the ability of highly purified pDCs, mDCs, and mono-DCs to produce IL-12 and IFN-α in response to each of the known TLRL (as detailed in the previous section) in the presence of CD40L (Figure 1 ). CD40L strongly promoted IFN-α production by pDCs induced by the TLR7Ls and the TLR9Ls. In contrast, CD40L failed to induce mDCs to produce IFN-α in combination with TLR2L, TLR4L, TLR5L, or TLT7/8L and failed to promote IFN-α production by mDCs induced by TLR3L. Dual signaling by CD40L in combination with the TLR7Ls or TLR9Ls did induce pDCs to produce small amounts of IL-12 p70 (97-199 pg/ml); however, dual signaling by CD40L plus the TLR3L or TLR8L synergistically promoted mDC subsets to produce 10 times more IL-12 p70 (1,548-2,547 pg/ml from mDCs and 2,187-2,604 pg/ml from monoDCs). Although individual signal by TLR2L or TLR5L failed to induce mDC subsets to produce bioactive IL-12 p70, dual signaling with these TLRLs and CD40L were capable of inducing IL-12 p70 production by mDCs, as previous paper demonstrated 18, 19 .
The ability of pDCs and mDCs to produce IFN-α and IL-12 was further examined by two-color staining by intracellular anti-IFN-α and anti-IL-12 at the single-cell level production.
The conclusion that pDC/IPCs have the capacity to produce as much IL-12 as mDCs was based on a study using human pDCs isolated by anti-BDCA4 magnetic beads and activation using CD40L plus CpG-ODN 9 . There are three major concerns about this study:
1) it is difficult to obtain a highly purified population of pDCs by magnetic bead separation;
2) BDCA4, also known as neuropilin-1, is expressed by not only pDCs, but also a small population of mDCs, CD3 + CD57 + T cells, and B cells 21 ; 3) using CD40L and CpG-ODN as stimuli to test the capacity of pDCs and mDCs to produce IL-12 is not appropriate, because while pDCs will be activated by both CD40L and CpG-ODN, human mDCs will be only.
For Figure 3A ). We found that more than 60% of these BDCA2 -cells expressed CD11c
and HLA-DR but not CD14 ( Figure 3A) , CD3, or CD56 (data not shown), indicating that 
pDC/IPCs promote IL-12 production by mDCs in response to TLRL or CD40L
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It has been reported that type I IFNs may positively or negatively regulate IL-12 production by mDCs depending on their maturation stage 22, 23 . We therefore hypothesized that after activation by CD40L plus CpG or R848, pDCs would be able to regulate IL-12 production by mDCs through type I IFNs. 
pDCs and B cells produce different cytokines in response to TLR7 and TLR9 signaling
Previous studies in both humans and mice showed that pDCs express many genes related to B lymphocytes, including RAG-1, RAG-2, Spi-B, and λ5, as well as IgH D-J gene rearrangements [24] [25] [26] . In the human system, both pDCs and B cells express TLR7 and TLR9 
and CD19
+ B cells were isolated from the same donor and cultured for 24 hour with each of the TLRLs plus CD40L and then cytokine production was analyzed by ELISA ( Figure 5 ).
mDCs produced large amounts of IL-10, TNF-α, and IL-6 as well as IL-12, but not IFN-α.
pDCs produced large amounts of IFN-α, TNF-α, and IL-6, but low IL-12 and no IL-10. B cells produced large amounts of IL-6, but low levels of IL-12, TNF-α, and IL-10 and no IFN-α. pDCs did not make detectable amounts of IL-10, and B cells did not make detectable amounts of IFN-α. These data suggest that although both pDCs and B cells express TLR7 and TLR9, they produce different cytokines in response to TLR7 and TLR9 signaling in the presence of CD40L. 
pDC/IPCs do not make secondary type I IFN responses
Dominant IFN-gene transcription in pDCs following viral activation
Immunoglobulin-secreting plasma cells contain abundant rearranged immunoglobulin mRNA transcript. Because pDCs are specialized in producing type I IFNs, we further investigated 1) whether pDCs contain pre-existing mRNA transcripts for type 1 IFNs before viral stimulation; 2) the kinetics of type I IFN mRNA transcription; and 3) the quantity of type 1 IFN transcripts compared with other gene transcripts. We found that pDCs do not contain pre-existing mRNA for type I IFNs before activation by viruses ( Figure 7A and B) . 
Repertoire of type I IFN responses by pDC/IPCs
In humans, type I IFN family consists of at least 13 IFN-α members, and single members of IFN-α1, IFN-β, IFN-ω, IFN-λ1 , and IFN-γ were also quantitatively confirmed by real-time PCR ( Figure 7E ). These data suggest that pDCs can produce a wide repertoire of type I IFNs in response to viral infection.
pDC/IPCs and mDCs express different sets of transcriptional factors critical for type I IFNs versus IL-12 synthesis.
To further understand the molecular basis underlying the specialization of pDCs and mDCs 
Discussion
By using highly purified human pDC and mDC subpopulations, we demonstrated that human pDCs preferentially produced IFN-α and mDCs preferentially produced IL-12 in response to TLR signaling or TLR and CD40 dual signaling. Using two-color intracellular only.
For Recent studies have further defined the molecular mechanisms underlying the unique function of pDCs as professional type I IFN-producing cells: 1) pDC/IPCs, but not other hematopoietic cell types, constitutively express high levels of IRF7, a critical transcriptional factor required for type I IFN production 33 . Upon TLR9 signaling, MyD88 recruits and directly interacts with IRF7 and the adaptor molecule TRAF6. This molecular supercomplex, together with IRAK4 and IRAK1, form a cytoplasmic transductionaltranscriptional processor for type I IFN production by pDCs 34, 35 ; 2) pDCs, but not other cell types, have a unique capacity to retain CpG-ODN in the endosome compartment for a prolonged period, allowing direct signaling through TLR9 within the endosome to trigger massive type I IFN production 36 .
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